chr7-30622471-T-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_002047.4(GARS1):c.1613+9T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,696 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 6.8e-7 ( 0 hom. )
Consequence
GARS1
NM_002047.4 intron
NM_002047.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0470
Publications
0 publications found
Genes affected
GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
GARS1 Gene-Disease associations (from GenCC):
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 7-30622471-T-A is Benign according to our data. Variant chr7-30622471-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 1160502.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GARS1 | ENST00000389266.8 | c.1613+9T>A | intron_variant | Intron 12 of 16 | 1 | NM_002047.4 | ENSP00000373918.3 | |||
| GARS1 | ENST00000675651.1 | c.1613+9T>A | intron_variant | Intron 12 of 16 | ENSP00000502513.1 | |||||
| GARS1 | ENST00000675810.1 | c.1511+9T>A | intron_variant | Intron 11 of 15 | ENSP00000502743.1 | |||||
| GARS1 | ENST00000675693.1 | c.1445+9T>A | intron_variant | Intron 13 of 17 | ENSP00000502174.1 | |||||
| GARS1 | ENST00000675051.1 | c.1412+9T>A | intron_variant | Intron 12 of 16 | ENSP00000502296.1 | |||||
| GARS1 | ENST00000674815.1 | c.1244+9T>A | intron_variant | Intron 12 of 16 | ENSP00000502799.1 | |||||
| GARS1 | ENST00000674851.1 | c.1244+9T>A | intron_variant | Intron 13 of 17 | ENSP00000502451.1 | |||||
| GARS1 | ENST00000444666.6 | n.1613+9T>A | intron_variant | Intron 12 of 17 | 3 | ENSP00000415447.2 | ||||
| GARS1 | ENST00000674616.1 | n.*1327+9T>A | intron_variant | Intron 13 of 17 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.*713+9T>A | intron_variant | Intron 13 of 16 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.*951+9T>A | intron_variant | Intron 13 of 17 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000674807.1 | n.1613+9T>A | intron_variant | Intron 12 of 15 | ENSP00000502814.1 | |||||
| GARS1 | ENST00000675529.1 | n.*1483+9T>A | intron_variant | Intron 13 of 17 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000675859.1 | n.1613+9T>A | intron_variant | Intron 12 of 14 | ENSP00000502033.1 | |||||
| GARS1 | ENST00000676088.1 | n.*1555+9T>A | intron_variant | Intron 14 of 18 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.*558+9T>A | intron_variant | Intron 12 of 16 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.*1064+9T>A | intron_variant | Intron 12 of 16 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.*902+9T>A | intron_variant | Intron 13 of 17 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.*1045+9T>A | intron_variant | Intron 12 of 16 | ENSP00000501980.1 | |||||
| GARS1 | ENST00000676403.1 | n.1613+9T>A | intron_variant | Intron 12 of 15 | ENSP00000502681.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461696Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727176 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
1
AN:
1461696
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
727176
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
0
AN:
33478
American (AMR)
AF:
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26126
East Asian (EAS)
AF:
AC:
0
AN:
39676
South Asian (SAS)
AF:
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
AC:
0
AN:
53398
Middle Eastern (MID)
AF:
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
1
AN:
1111900
Other (OTH)
AF:
AC:
0
AN:
60376
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Benign:1
Feb 03, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.